Mehmet Yavuz is 62 yo. He presented to the clinic and after having an HbA1c test (result 9%) was diagnosed with type 2 Diabetes mellitus.His cardiovascular risk was > 15% http://www.cvdcheck.org.au/His renal health screen showed an eGFR 90 mL/min/1.73m2 with microalbuminuria of 3.5 mg/mmol. http://www.kidney.org.au/HealthProfessionals/DetectingCKD/tabid/632/Default.aspxHe attended a podiatry appointment which detected decreased dorsalis pedis and posterior tibialis pulses in both legs. Management of his condition now includes the following:Exercise: at least 150 minutes of aerobic and 60 minutes of resistance exercise each weekDiet: a plan worked out with an accredited dietician based on the Australian Dietary Guidelines (2013).Drug use: smoking cessation plan to stop cigarette use; alcohol consumption reduction to 1 - 2 full strength beers every second dayWeight loss: Mehmet aims to lose 5 kg over the first 6 - 8 weeks after diagnosisMedications:Jardiamet (empagliflozin 5mg, metformin 500 mg), twice daily, with or after foodramipril 5 mg, dailyRosuzet (rosuvastatin 20mg, ezetimibe 10mg), dailyOngoing diagnostics:HbA1c: every 3 monthslipid profile: every 3 monthsrenal function assessment: annuallypodiatrist assessment: at least once a yearoptometrist assessment: at least once a year QUESTION:ONLY DISSCUSS ABOUT metformin based on each questions below.describe the mechanism of ACTION/S of metformin identify the AIM of metformin therapy for Mehmetrelate metformin therapy to Mehmet's pathophysiological presentationrefer briefly to any australian GUIDELINES which support the use of metformin medicationidentify one RISK or special consideration for Mehmet whilst taking metforminidentify what evidence will demonstrate the EFFECTIVENESS of metformin therapy

Introduction- Diabetes is a chronic metabolic disorder, that results in increased glucose level in…

Answered: QUESTION: ONLY DISSCUSS ABOUT…

6th Edition

ISBN:9781451194524

Author:Ruth McCall, Cathee M. Tankersley MT(ASCP)

Publisher:Ruth McCall, Cathee M. Tankersley MT(ASCP)

Chapter1: Phlebotomy: Past And Present And The Healthcare Setting

Section: Chapter Questions

Problem 1SRQ

Related questions

Question

Mehmet Yavuz is 62 yo. He presented to the clinic and after having an HbA1c test (result 9%) was diagnosed with type 2 Diabetes mellitus.

His cardiovascular risk was > 15% http://www.cvdcheck.org.au/

His renal health screen showed an eGFR 90 mL/min/1.73m² with microalbuminuria of 3.5 mg/mmol.

http://www.kidney.org.au/HealthProfessionals/DetectingCKD/tabid/632/Default.aspx

He attended a podiatry appointment which detected decreased dorsalis pedis and posterior tibialis pulses in both legs.

Management of his condition now includes the following:

Exercise: at least 150 minutes of aerobic and 60 minutes of resistance exercise each week
Diet: a plan worked out with an accredited dietician based on the Australian Dietary Guidelines (2013).
Drug use: smoking cessation plan to stop cigarette use; alcohol consumption reduction to 1 - 2 full strength beers every second day
Weight loss: Mehmet aims to lose 5 kg over the first 6 - 8 weeks after diagnosis

Medications:

Jardiamet (empagliflozin 5mg, metformin 500 mg), twice daily, with or after food
ramipril 5 mg, daily
Rosuzet (rosuvastatin 20mg, ezetimibe 10mg), daily

Ongoing diagnostics:

QUESTION:

ONLY DISSCUSS ABOUT metformin based on each questions below.

describe the mechanism of ACTION/S of metformin
identify the AIM of metformin therapy for Mehmet
relate metformin therapy to Mehmet's pathophysiological presentation
refer briefly to any australian GUIDELINES which support the use of metformin medication
identify one RISK or special consideration for Mehmet whilst taking metformin
identify what evidence will demonstrate the EFFECTIVENESS of metformin therapy

Expert Solution